A Phase I Trial of LY2510924, a CXCR4 Peptide Antagonist,...

Clinical Cancer Research 2014 / 07 Vol. 20; Iss. 13

A Phase I Trial of LY2510924, a CXCR4 Peptide Antagonist, in Patients with Advanced Cancer

Galsky, M. D., Vogelzang, N. J., Conkling, P., Raddad, E., Polzer, J., Roberson, S., Stille, J. R., Saleh, M., Thornton, D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
20
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-13-2686
Date:
July, 2014
File:
PDF, 502 KB
english, 2014
Conversion to is in progress
Conversion to is failed